Journal of the Economics of Ageing, published by ELSEVIER, is a leading international journal dedicated to exploring the economic aspects of ageing in the global context. With an ISSN of 2212-828X, it aims to provide a platform for innovative research that addresses the socio-economic implications of demographic shifts, particularly those related to life-span and life-course studies. Since its inception in 2013, the journal has rapidly established itself within the Q2 category in both the Economics and Econometrics and Life-span and Life-course Studies fields, reflecting its significant contribution to these disciplines. Based in the Netherlands, this journal is indexed with a respectable percentile ranking, such as 69th in Life-span and Life-course Studies, confirming its value to researchers and professionals alike. Committed to disseminating impactful research, the Journal of the Economics of Ageing ultimately seeks to influence policy and funding decisions that shape the future of ageing populations.

Health Policy OPEN is an esteemed open-access journal published by Elsevier that has made significant contributions to the field of health policy since its inception in 2020. With an impact factor placing it in the prestigious Q2 category of health policy journals, it ranks 116 out of 310 within the Scopus database, highlighting its critical engagement in the field and situating it within the 62nd percentile. As an open-access platform, Health Policy OPEN promotes the dissemination of high-quality research, making it accessible to a global audience of researchers, professionals, and students alike. The journal focuses on topical issues, innovative approaches, and evidence-based practices that shape health policies worldwide. With its headquarters in Amsterdam, Netherlands, the journal serves as a vital resource for advancing knowledge and fostering discussions that drive health policy initiatives and reforms. Engage with Health Policy OPEN to contribute to the evolving landscape of health policy and to stay informed on the latest research advancements.

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.

BMC Health Services Research is a leading open-access journal dedicated to advancing the field of health policy and services research. Published by BMC since 2001 and based in the United Kingdom, this journal has established itself as an essential resource for researchers, professionals, and students alike, fostering a deeper understanding of health care systems and policies. With an impressive 2023 Q1 ranking in the Health Policy category and a Scopus rank of 90/310, it clearly demonstrates its commitment to high-quality, impactful research. The journal's open-access model ensures that research findings are accessible to a global audience, promoting collaboration and innovation in health services. Spanning from 2001 to 2024, BMC Health Services Research is poised to remain at the forefront of health services research, making significant contributions to policy formulation and practice improvement in the healthcare sector.

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

PHARMACOECONOMICS, published by ADIS INT LTD, is a prestigious international journal dedicated to disseminating research in the fields of health policy, pharmacology, and public health. With an impressive impact factor and a solid Q1 ranking across its relevant categories, this journal plays a crucial role in shaping policy decisions, optimizing health resources, and enhancing pharmacoeconomic evaluations globally. The journal not only targets researchers and professionals but also serves as an invaluable resource for students striving to understand the economic implications of pharmaceutical care. Operating since 1992 and continuously evolving through 2024, PHARMACOECONOMICS invites contributions that address the complexities of drug expenditure, health outcomes, and public health implications, thereby fostering informed decision-making in healthcare systems. Readers can explore cutting-edge studies and analyses aimed at balancing cost-effectiveness with clinical effectiveness, making this journal a cornerstone for stakeholders invested in the future of health economics.

Pharmacoeconomics-Open, an esteemed journal published by SPRINGER INT PUBL AG, is a vital resource for scholars and practitioners in the fields of health policy and pharmacology. Since its transition to an Open Access platform in 2017, the journal has aimed to democratize access to valuable research, fostering innovation and collaboration globally. With notable rankings in the 2023 Scopus indices—including Q2 in Health Policy and both categories of Pharmacology—Pharmacoeconomics-Open engages with pressing issues in health economics, providing insights into cost-effectiveness analyses and healthcare decision-making. The journal’s commitment to high-quality, peer-reviewed articles ensures that it remains a significant player in advancing knowledge and understanding within its disciplines, serving as an essential forum for researchers, policymakers, and students alike.

HEALTH POLICY is a leading academic journal dedicated to the examination and analysis of health policy issues globally, published by Elsevier Ireland Ltd. With an impressive Q1 classification in the field of Health Policy, as indicated by its Scopus ranking of #44 out of 310 and an 85th percentile standing, this journal serves as a critical platform for researchers, practitioners, and policymakers interested in the complexities of health systems and the impact of policy decisions. Since its inception in 1984 and continuing through 2024, HEALTH POLICY has consistently contributed to the discourse surrounding health services, equity, and sustainability, providing access to original research, thorough reviews, and insightful commentaries. Although it operates under a traditional subscription model, the journal is essential for those seeking to stay informed on contemporary challenges and emerging trends in health policy.

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.